Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Biliary Tract Neoplasms × cediranib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 1 Lung Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 4 Cisplatin 4 Capecitabine 4 Oxaliplatin 3 Leucovorin 2 Fluorouracil 2 Albumin-Bound Paclitaxel 2 titanium silicide 1 tegafur-gimeracil-oteracil 1 surufatinib 1 mitazalimab 1 durvalumab 1 cediranib 1 anlotinib 1 Taxes 1 S 1 (combination) 1 Folfox protocol 1 Control Groups 1 ARRY-334543 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00939848 2014-10-27

ABC-03

University College, London

Phase 2/3 Completed

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡